David Pyott expected 2014 to be a year of hunting for deals. The tables were turned when Allergan Inc., the Irvine-based drugmaker he’s led for the past 16 years, became the hunted. “Normally, very ...

David Pyott opened 2006 with a flourish. Allergan Inc., the Irvine-based drug maker he’s run for the past eight years, prevailed with a trumping $3.2 billion bid for Inamed Corp., a coveted maker of ...

Please provide your email address to receive an email when new articles are posted on . With the acquisitions and mergers and the major pharmaceutical and refractive launches that have taken place ...

Dr. David Pyott, Director, Pliant Therapeutics Inc. Dr. Pyott joins the Pliant Board of Directors with more than 30 years of executive leadership and management experience within the global ...

Talk about golden parachutes: Allergan’s Chief Executive Officer, David Pyott, could collect as much as $126 million after the company he’s run for the past 17 years is acquired by Ireland-based ...

NEW YORK (Reuters) - Actavis Plc (ACT.N) said on Tuesday that Allergan Inc's (AGN.N) top executive David Pyott will not join the combined company's board of directors after all. Pyott, who had run ...

Please provide your email address to receive an email when new articles are posted on . Sienna Biopharmaceuticals announced in a press release that David E.I. Pyott, MBA, former chairman and CEO of ...

Is a position as one of the industry's top-paid CEOs enough to prompt Allergan's ($AGN) chief to dis Valeant's ($VRX) buyout efforts? Investor and takeover partner ...

Job: Chairman and CEO, Allergan Inc. Bio: Led the nutrition division at the Swiss drug company Novartis. Since becoming Allergan’s CEO, in 1998, the company’s annual sales have jumped more than ...